RxDoctor Payments Data

Avigayil Rapp

Internal Medicine · Inwood, NYNPI 1427411743

Payments from drug & device makers

What this record shows

This record is dominated by travel and lodging: $1,041 of the $1,390 with a category attached, or 74.9%. Merck accounts for 91.7% of it on its own, with 2 other manufacturers making up the rest.

$1,390in general payments, 2019–2025

Across 10 payments — averaging $139.03 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Merck$1K
  • F. Hoffmann-la Roche AG$80
  • Boehringer Ingelheim$35
$1,822,762in research payments, 2019–2025

Across 607 payments — averaging $3002.90 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Takeda Pharmaceuticals U.S.A., Inc.$1.8M
  • Boehringer Ingelheim International GmbH$33K
  • Amgen$17K
  • E.r. Squibb & Sons, L.L.C.$2K

What the payments were for

  • Travel & lodging$1,04175%
  • Food & beverage$34925%

General payments by program year

24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Merck8$1,275
F. Hoffmann-la Roche AG1$80
Boehringer Ingelheim1$35

How this compares

$1,390 in reported general payments places this provider in the 75th percentile of 9,771 internal medicine providers in New York.

See all internal medicine providers in New York

Other internal medicine in Inwood

See the full list for New York

Where these figures come from

Is this you, or does something look wrong? →